Former Labour justice minister Shahid Malik, 57, helped set up 'fraudulent Covid testing firm that made £6.6m in three weeks', court told

Malik, 57, is accused of establishing the 'cash cow' firm alongside a pharmacist, a registered scientist and his own former ...

Trading Plan: Can Nifty 50, Bank Nifty break previous day’s high on Muhurat Trading?

The Nifty 50 index is expected to face resistance at the 25,900–26,000 zone on the Muhurat Trading day, while support is ...
MedPage Today

'Remarkable' Survival Outcomes in Cisplatin-Ineligible Bladder Cancer

Event-free survival (EFS) improved by 60% and overall survival (OS) by 50% with the antibody-drug conjugate (ADC) enfortumab vedotin (Padcev) plus pembrolizumab (Keytruda) versus upfront radical ...
Targeted Oncology

DESTINY-Breast11: Neoadjuvant T-DXd/THP Improves pCR in High-Risk HER2+ BC

“DESTINY-Breast11 results support T-DXd [plus] THP as a more effective and less toxic neoadjuvant treatment compared with ddAC-THP, and it may become the preferred regimen for patients with high-risk, ...
CURE

Presurgical Enhertu Combo Elicits Response Benefit in HER2+ Early Breast Cancer

Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early ...
Fierce Pharma

ESMO: Keytruda, Padcev reduce risk of death by 50% in another massive showing in bladder cancer

The combination of Merck’s Keytruda and Pfizer and Astellas’ Padcev reduced patients' risk of death by a whopping 50% when used before and after bladder removal surgery in those with MIBC who are not ...
CURE

Imfinzi Plus Chemo Improves Survival in G/GEJ Adenocarcinoma

Imfinzi plus FLOT chemotherapy significantly improves overall survival in resectable G/GEJ adenocarcinoma compared to placebo ...